Table 2 Baseline characteristics of participants enrolled in the 2017–2018 therapeutic efficacy study, Burkina Faso
Niangoloko | Nanoro | Gourcy | ||||
|---|---|---|---|---|---|---|
AL | DP | AL | DP | AL | DP | |
Screened | 375 | 335 | 324 | |||
Included in analysis (%) | 116 | 118 | 117 | 113 | 120 | 118 |
Age in months. mean (SD) | 33.6 (13.2) | 33.6 (13.2) | 33.6 (13.2) | 31.2 (12.0) | 34.8 (12.0) | 34.8 (12.0) |
Sex (male) n (%) | 58 (50) | 68 (57.6) | 57 (48.7) | 61 (53.0) | 59 (49.2) | 62 (52.5) |
Weight (kg). mean (SD) | 12.0 (2.7) | 12.1 (2.7) | 11.6 (2.0) | 11.2 (2.2) | 11.8 (2.2) | 11.7 (2.3) |
Temperature in °C, mean (SD) | 38.3 (1.0) | 38.3 (1.0) | 38.2 (1.1) | 38.1 (1.1) | 38.1 (1.2) | 38.2 (1.0) |
Parasitaemia day 0a | 36,594 | 36,571 | 48,891 | 42,393 | 42,116 | 33,536 |
Hemoglobin in g/dl. mean (SD) | 10.2 (1.7) | 10.0 (2.9) | 9.9 (1.7) | 10.1 (1.6) | 10.0 (1.5) | 9.9 (1.6) |